Click here for more from the Washington Post and here for more from the Wall Street Journal
Price varies and insurance coverage differs widely
Patients report increased cravings, larger portion sizes, and a return of food preoccupation
SURPASS-1: Tirzepatide shows powerful glucose and weight loss benefits for type 2 diabetes SURPASS-1 investigated tirzepatide in 478 adults with type 2 diabetes who needed treatment beyond diet and exercise to manage their blood sugar levels
Additionally, a prespecified exploratory analysis showed 60% of participants on the highest, 15-mg dose of tirzepatide (Eli Lilly) achieved a composite endpoint of an HbA1c of 6.5% or lower and weight loss of 10% or greater with no reports of severe hypoglycemia, compared with 22% of participants assigned 1 mg semaglutide (Ozempic, Novo Nordisk)
Here are a few key resources: Healthcare Professional Support : Regular consultations with doctors, dietitians, and other specialists can provide you with personalised advice and support
)
